Radiation therapy, when given in conjunction with a newly formulated chemotherapy regimen, improves survival rates up to 12 months for patients with inoperable non-small cell lung cancer. READ MORE

Conferences

One assay test reveals statistically lower levels of PD-L1 expression than the others.

READ MORE

Results show that hypofractionated radiation therapy may be a better treatment option for patients with non-small cell lung cancer.

READ MORE

Using a web application developed by French researchers may help clinicans to better manage follow-up for patients with lung cancer.

READ MORE

News

Radiation therapy, when given in conjunction with a newly formulated chemotherapy regimen, improves survival rates up to 12 months for patients with inoperable non-small cell lung cancer.

READ MORE

Patients with advanced, EGFR-mutant non-small cell lung cancer live almost twice as long without disease progression after initial treatment with an EGFR inhibitor compared with standard of care tyrosine kinase inhibitor therapy.

READ MORE

A recent comparison between commonly-used therapies for untreated, advanced ALK-positive NSCLC demonstrated superior efficacy and lower toxicity for one therapy.

READ MORE

Researchers have identified a new outcome measurement that should be considered a practical clinical end point for early evaluation in emerging therapies for non-small cell lung cancer.

READ MORE

Research in Review

Increasing the standard dose of an ALK inhibitor for the treatment of NSCLC improves objective response rates by 9% with limited additional toxicity.

READ MORE

According to recent research published in the International Journal of Radiation Oncology, which form of therapy is effective in older patients with early stage lung cancer?

READ MORE

Stereotactic body radiation therapy is a safe treatment for patients aged 80 years or older with early-stage lung cancer.

READ MORE

Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows.

READ MORE

Slideshow

The Food and Drug Administration (FDA) approved more than 20 new drugs and indications for the treatment of cancer in the last year. Review the drugs that were approved to treat specific forms of lung cancer and the results that led to the FDA decisions.

READ MORE